TG Therapeutics, Inc. (TGTX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 8.77 |
| Open | 8.81 |
| Bid | 8.25 x 1000 |
| Ask | 8.42 x 1400 |
| Day's Range | 8.14 - 8.88 |
| 52 Week Range | 4.86 - 35.67 |
| Volume | |
| Avg. Volume | 5,011,669 |
| Market Cap | 1.262B |
| Beta (5Y Monthly) | 2.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.26 |
| Earnings Date | Nov 08, 2023 - Nov 13, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.94 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for TGTX
Related Research
- TG Therapeutics, Inc.Daily – Vickers Top Buyers & Sellers for 08/15/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat2 months agoArgus Research
GlobeNewswireTG Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
Fireside chat scheduled for Tuesday, September 26, 2023, at 12:25 PM ETNEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 2023 Cantor Global Healthcare Conference, being held at the Intercontinental Barclay Hotel, in New York City on September 26 - 28, 2023. The fireside chat is scheduled to take place on Tuesday, September 26, 2023, at 12:25 PM ET. A
Simply Wall St.TG Therapeutics, Inc.'s (NASDAQ:TGTX) institutional investors lost 8.3% last week but have benefitted from longer-term gains
Key Insights Institutions' substantial holdings in TG Therapeutics implies that they have significant influence over...
- GlobeNewswire
TG Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Fireside chat scheduled for Monday, September 11, 2023, at 10:30 AM ETNEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the H.C. Wainwright 25th Annual Global Investment Conference, being held at the Lotte New York Palace Hotel, in New York City on September 11 - 13, 2023. The fireside chat is scheduled to take place on Monday, September 11, 2023, at 10:3
